Top Markets
Coin of the day
Shanghai Kaibao Pharmaceutical CO.,Ltd Shanghai Kaibao Pharmaceutical CO.,Ltd

Shanghai Kaibao Pharmaceutical CO.,Ltd

300039
주식 순위 #10244
Shanghai Kaibao Pharmaceutical CO.,Ltd specializes in the research,... Shanghai Kaibao Pharmaceutical CO.,Ltd specializes in the research, development, manufacturing, and sale of modern Traditional Chinese Medicines, primarily operating within China. Its diverse product lineup features several key pharmaceutical solutions. These include: Tanreqing injection, which is extensively utilized for addressing conditions like pneumonia, acute and chronic bronchitis, and upper respiratory tract infections. Tanreqing capsules, formulated to reduce internal heat, detoxify the system, and clear phlegm. Tiopronin for injection, designed to enhance liver function for various acute and chronic hepatitis patients. Tiopronin enteric-coated tablets, prescribed as a supplementary therapy for managing chronic hepatitis. Xiongdan dropping pills, known for their efficacy in alleviating heat, calming the liver, and promoting improved vision. Established in 2000, the company's operations are based in Shanghai, China.
주가
$0.82890742
마지막 동기화: 2026-08-28
시가총액
$867.04M
변동 (1일)
-4.19%
변동 (1년)
-5.58%
국가
CN
거래 Shanghai Kaibao Pharmaceutical CO.,Ltd (300039)

카테고리

Shanghai Kaibao Pharmaceutical CO.,Ltd (300039)의 EPS
2026 기준 EPS TTM: 0
Shanghai Kaibao Pharmaceutical CO.,Ltd의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Shanghai Kaibao Pharmaceutical CO.,Ltd의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.